Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

2.
3.

Hyperglycemia and antipsychotic medications.

Haupt DW, Newcomer JW.

J Clin Psychiatry. 2001;62 Suppl 27:15-26; discussion 40-1. Review.

4.

Rapid onset of quetiapine-induced diabetic ketoacidosis in an elderly patient: a case report.

Takahashi M, Ohishi S, Katsumi C, Moriya T, Miyaoka H.

Pharmacopsychiatry. 2005 Jul;38(4):183-4.

PMID:
16025424
5.

Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics.

Henderson DC, Cagliero E, Copeland PM, Louie PM, Borba CP, Fan X, Freudenreich O, Goff DC.

J Clin Psychiatry. 2007 Apr;68(4):533-41.

PMID:
17474808
6.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

8.

Diabetic ketoacidosis among patients receiving clozapine: a case series and review of socio-demographic risk factors.

Nihalani ND, Tu X, Lamberti JS, Olson D, Olivares T, Costea GO, Tang W.

Ann Clin Psychiatry. 2007 Apr-Jun;19(2):105-12. Review. Erratum in: Ann Clin Psychiatry. 2007 Oct-Dec;19(4):329. Tu, Xin [added].

PMID:
17612850
9.

Factors in antipsychotic drug selection: tolerability considerations.

Nasrallah HA.

CNS Spectr. 2003 Nov;8(11 Suppl 2):23-5.

PMID:
14978455
10.

Risk of diabetes mellitus associated with atypical antipsychotic use among Medicaid patients with bipolar disorder: a nested case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

Pharmacotherapy. 2007 Jan;27(1):27-35.

PMID:
17192159
11.

New-onset type-2 diabetes associated with atypical antipsychotic medications.

Lambert MT, Copeland LA, Sampson N, Duffy SA.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jul;30(5):919-23. Epub 2006 Apr 3.

PMID:
16581171
12.

Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.

Guo JJ, Keck PE Jr, Corey-Lisle PK, Li H, Jiang D, Jang R, L'Italien GJ.

J Clin Psychiatry. 2006 Jul;67(7):1055-61.

PMID:
16889448
13.

New onset diabetes and atypical antipsychotics.

Liebzeit KA, Markowitz JS, Caley CF.

Eur Neuropsychopharmacol. 2001 Feb;11(1):25-32. Review.

PMID:
11226809
14.

Atypical antipsychotic drug use and diabetes.

Ananth J, Venkatesh R, Burgoyne K, Gunatilake S.

Psychother Psychosom. 2002 Sep-Oct;71(5):244-54.

PMID:
12207104
15.

The implications of weight changes with antipsychotic treatment.

Sussman N.

J Clin Psychopharmacol. 2003 Jun;23(3 Suppl 1):S21-6. Review.

PMID:
12832946
17.

Atypical antipsychotics and glucose homeostasis.

Bergman RN, Ader M.

J Clin Psychiatry. 2005 Apr;66(4):504-14. Review.

PMID:
15816794
18.

Atypical antipsychotics and diabetic ketoacidosis: a review.

Guenette MD, Hahn M, Cohn TA, Teo C, Remington GJ.

Psychopharmacology (Berl). 2013 Mar;226(1):1-12. doi: 10.1007/s00213-013-2982-3. Epub 2013 Jan 24. Review.

PMID:
23344556
19.

[Schizophrenia, diabetes mellitus and antipsychotics].

Gury C.

Encephale. 2004 Jul-Aug;30(4):382-91. Review. French.

PMID:
15538314
20.

Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics.

Citrome LL, Holt RI, Zachry WM, Clewell JD, Orth PA, Karagianis JL, Hoffmann VP.

Ann Pharmacother. 2007 Oct;41(10):1593-603. Epub 2007 Sep 4. Review.

PMID:
17785613

Supplemental Content

Support Center